GlassScriptPhysician profile
Robert Teiano Lesa
NPI 1831292408
$999.46
in general payments reported to CMS, 2019-2025
11 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $269 · 2022: $93.25 · 2023: $165 · 2024: $233 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $635.20 | 2021-2025 | Mako |
| Boston Scientific Corporation | $54.98 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Pacira Pharmaceuticals Incorporated | $46.84 | 2024 | Exparel |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.78 | 2024 | Relistor |
| Bioventus LLC | $44.70 | 2022-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $41.78 | 2021-2023 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $40.31 | 2025 | |
| Globus Medical, INC. | $39.14 | 2024 | Clavicular Fracture Fixation, Ankle Fracture System |
| Sanofi-Aventis U.S. LLC | $20.25 | 2023 | |
| Collegium Pharmaceutical, INC. | $18.50 | 2023 | Xtampza |
| Relievant Medsystems, INC. | $12.98 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lesa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.